Romania - rumensk - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

actavis group ptc ehf. - islanda - imatinibum - compr. film. - 100mg - alte antineoplazice inhibitori de protein-kinaza

Romania - rumensk - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

actavis group ptc ehf. - islanda - imatinibum - compr. film. - 400mg - alte antineoplazice inhibitori de protein-kinaza

Irland - engelsk - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - imatinib mesilate - film-coated tablet - 100 milligram(s) - other antineoplastic agents - antineoplastic agents, protein kinase inhibitor - imatinib actavis group is indicated for the treatment of - paediatric patients with newly diagnosed philadelphia chromosome (bcr-abl) positive (ph+) chronic myeloid leukaemia (cml) for whom bone marrow transplantation is not considered as the first line of treatment. - paediatric patients with ph+ cml in chronic phase after failure of interferon-alpha therapy, or in accelerated phase or blast crisis. - adult patients with ph+ cml in blast crisis. - adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) integrated with chemotherapy. - adult patients with relapsed or refractory ph+ all as monotherapy. - adult patients with myelodysplastic/myeloproliferative diseases (mds/mpd) associated with platelet-derived growth factor receptor (pdgfr) gene re-arrangements. - adult patients with advanced hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) with fip1l1-pdgfr
rearrangement.

Romania - rumensk - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

actavis group ptc ehf. - islanda - lisinoprilum - compr. - 5mg - inhibitori ai enzimei de conversie a angiotensinei inhibitori ai enzimei de conversie a angiotensinei

Romania - rumensk - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

actavis group ptc ehf. - islanda - lisinoprilum - compr. - 20mg - inhibitori ai enzimei de conversie a angiotensinei inhibitori ai enzimei de conversie a angiotensinei

Romania - rumensk - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

actavis group ptc ehf. - islanda - lisinoprilum - compr. - 10mg - inhibitori ai enzimei de conversie a angiotensinei inhibitori ai enzimei de conversie a angiotensinei

Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

actavis group ptc ehf. (8092378) - omeprazol - magensaftresistente hartkapsel - teil 1 - magensaftresistente hartkapsel; omeprazol (22284) 40 milligramm

Kroatia - kroatisk - HALMED (Agencija za lijekove i medicinske proizvode)

actavis group ptc ehf, reykjavikurvegur 76-78, hafnarfjordur, island - imatinibum - filmom obložena tableta - 100 mg - urbroj: svaka filmom obložena tableta sadrži 119,5 mg imatinibmesilata što odgovara 100 mg imatiniba

Kroatia - kroatisk - HALMED (Agencija za lijekove i medicinske proizvode)

actavis group ptc ehf, reykjavikurvegur 76-78, hafnarfjordur, island - imatinibum - filmom obložena tableta - 200 mg - urbroj: svaka filmom obložena tableta sadrži 239 mg imatinibmesilata što odgovara 200 mg imatiniba

Kroatia - kroatisk - HALMED (Agencija za lijekove i medicinske proizvode)

actavis group ptc ehf, reykjavikurvegur 76-78, hafnarfjordur, island - imatinibum - filmom obložena tableta - 300 mg - urbroj: svaka filmom obložena tableta sadrži 358,5 mg imatinibmesilata što odgovara 300 mg imatiniba